Growing Need for Companion Diagnostics is Evident at Drug Discovery Event
The momentum for targeted therapies has downstream implications for clinical laboratories
Already a member? Log in here
Testing Trends-dtet
What the $1b Roche-PathAI Deal Can Tell Clinical Lab Directors
Roche acquires a workflow rather than a company, says AI industry observer
Already a member? Log in here
Diagnostics Pipeline: Expanded DPYD Test Anticipated to Make Chemotherapy Safer
Labcorp’s new genotyping test can identify gene variants that may make standard oncologic treatment deadly for some
Already a member? Log in here
New Strategies Increase HCV Testing in Primary Care, ER and Linkages to Care
...
Already a member? Log in here
Mass Spec Receiving Broader Application
From – Diagnostic Testing & Emerging Technologies
Mass spectrometry (MS) is rapidly transitioning from specialized clinical testing—drugs of abuse confirmations, newborn screening, and steroid analysis—to being broadly applied throughout…
Already a member? Log in here
Molecular Autopsy Becoming Viable to Implement
...
Already a member? Log in here
Criteria-Based Ordering Improves Vitamin D Testing
...
Already a member? Log in here
Evidence Emerging for More Use Cases for High-Sensitivity Troponin
...
Already a member? Log in here
USPSTF Updates Colorectal Cancer Screening Guidelines to Include Molecular Test
From – Diagnostic Testing & Emerging Technologies
The U.S. Preventive Services Task Force (USPSTF) added molecular colorectal cancer (CRC) screening to its newly updated guidelines, but stopped short of…
Already a member? Log in here
Large Panels Complicate Results Reporting for Breast Cancer Risk
...
Already a member? Log in here
Orgs Plan for Personalized Medicine Growth over Next Few Years
From – Diagnostic Testing & Emerging Technologies
Health care experts predict growth and maturation happening in the field of personalized medicine in the next two…
Already a member? Log in here
Prospective Trial Shows Utility of Liquid Biopsy for Lung Cancer
...
Already a member? Log in here